Form D · Other Banking and Financial Services
Genome Finance LLC
Phoenix, AZ · CIK 0001849284
Offering snapshot reported Mar 15, 2021 · SEC filing
- Reported sold
- $900K Offering amount: $15M
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $50K Reported outside-investor minimum
- First sale
- Feb 28, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 15, 2021 | Initial | $900,000 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-392312
Source: Form D, filed Mar 15, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Llc Keystone Advisors, | Director, Executive, Promoter |
| Todd Stottlemyre | Director, Executive, Promoter |
| Llc Stottlemyre International, | Director, Executive, Promoter |
Issuer details
Industry: Other Banking and Financial Services (See others in industry)
Address:
3104 E. Camelback Road Suite 2147
Phoenix, AZ, 85016
Phoenix, AZ, 85016